<> Krebs Biochemicals & Industries Share Price Today: Live Krebs Biochemicals & Industries Share Price NSE/BSE | 5paisa
KREBSBIO

Krebs Biochemicals & Industries Share PriceKrebs Biochemicals & Industries

₹97.00
-1.8 (-1.82%)
As on 05 February, 2023 | 18:50 BSE: 524518 NSE: KREBSBIO

Krebs Biochemicals & Industries Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Krebs Biochemicals & Industries

Start SIP

Krebs Biochemicals & Industries Share Price

  • Over 1 Month -15.21%
  • Over 3 Month -14.69%
  • Over 6 Month -12.3%
  • Over 1 Year -43.75%

Krebs Biochemicals & Industries Key Statistics

P/E Ratio -7.2
PEG Ratio -0.3
Market Cap Cr 209
Price to Book Ratio -2.8
EPS -20.7
Dividend 0
Relative Strength Index 30.04
Money Flow Index 11.84
MACD Signal -2.63
Average True Range 4.36

Krebs Biochemicals & Industries Investment Rating

  • Master Rating:
  • Krebs Biocs.& Inds. has an operating revenue of Rs. 57.76 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of -75% needs improvement, NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 12 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Krebs Biochemicals & Industries Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 9211018
Operating Expenses Qtr Cr 12231729
Operating Profit Qtr Cr -3-2-7-11
Depreciation Qtr Cr 2222
Interest Qtr Cr 1100
Tax Qtr Cr 0000
Net Profit Qtr Cr -6-4-8-11

Krebs Biochemicals & Industries Technicals

EMA & SMA

Current Price
₹97.
-1.8 (-1.82%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 103.3
  • 50 Day
  • 107.37
  • 100 Day
  • 110.92
  • 200 Day
  • 117.83
  • 20 Day
  • 103.94
  • 50 Day
  • 109.08
  • 100 Day
  • 111.14
  • 200 Day
  • 115

Krebs Biochemicals & Industries Resistance and Support

PIVOT
₹99.35
Resistance
First Resistance 100.2
Second Resistance 101.6
Third Resistance 102.45
RSI 30.04
MFI 11.84
MACD Single Line -2.63
MACD -3.35
Support
First Resistance 97.95
Second Resistance 97.1
Third Resistance 95.7

Krebs Biochemicals & Industries Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 15,566 1,142,077 73.37
Week 9,571 694,060 72.52
1 Month 11,845 852,457 71.97
6 Month 23,091 1,242,535 53.81

Krebs Biochemicals & Industries Result Highlights

Krebs Biochemicals & Industries Synopsis

NSE-Medical-Generic Drugs

Krebs Biochemicals & belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 59.70 Cr. and Equity Capital is Rs. 21.56 Cr. for the Year ended 31/03/2022. Krebs Biochemicals & Industries Ltd. is a Public Limited Listed company incorporated on 02/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110AP1991PLC103912 and registration number is 103912.
Market Cap 205
Sales 58
Shares in Float 0.58
No of funds 6
Yield
Book Value -10.12
U/D Vol ratio 0.8
LTDebt / Equity
Alpha -0.18
Beta 1.06

Krebs Biochemicals & Industries

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 72.72%72.74%72.74%
Foreign Portfolio Investors 0.33%0.01%0.01%
Financial Institutions/ Banks
Individual Investors 18.68%18.78%19.26%
Others 8.27%8.47%7.99%

Krebs Biochemicals & Industries Management

Name Designation
Dr. R T Ravi Chairman & Non-Exe.Director
Mr. Pabitrakumar Kalipada Bhattacharyya Managing Director
Mr. Jitendra Shah Non Executive Director
Mr. G V L Prasad Independent Director
Mr. Raj Kamal Prasad Verma Independent Director
Dr. Tangirala Malati Independent Director
Mr. Satish Khivsara Independent Director
Mr. Avinash Ravi Non Executive Director

Krebs Biochemicals & Industries Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Krebs Biochemicals & Industries Corporate Action

Date Purpose Remarks
2023-02-03 Quarterly Results
2022-11-10 Quarterly Results
2022-08-01 Quarterly Results
2022-05-23 Audited Results
2022-02-12 Quarterly Results

Krebs Biochemicals & Industries FAQs

What is Share Price of Krebs Biochemicals & Industries ?

Krebs Biochemicals & Industries share price is ₹97 As on 05 February, 2023 | 18:36

What is the Market Cap of Krebs Biochemicals & Industries ?

The Market Cap of Krebs Biochemicals & Industries is ₹209.1 Cr As on 05 February, 2023 | 18:36

What is the P/E ratio of Krebs Biochemicals & Industries ?

The P/E ratio of Krebs Biochemicals & Industries is -7.2 As on 05 February, 2023 | 18:36

What is the PB ratio of Krebs Biochemicals & Industries ?

The PB ratio of Krebs Biochemicals & Industries is -2.8 As on 05 February, 2023 | 18:36

Q2FY23